SB202190 FHPI size: 100 mg
SB202190 (FHPI) is a potent and selective p38 MAP kinase inhibitor widely used in cell signaling, apoptosis studies, inflammation research, and cancer biology. This high-purity inhibitor is supplied in a 100 mg vial, making it ideal for biochemical assays, kinase pathway analysis, and molecular pharmacology experiments.
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.